Names | |
---|---|
IUPAC name
(RS)-1-[4-[3-(tert-Butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
ECHA InfoCard | 100.228.618 |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C20H33N3O3 | |
Molar mass | 363.502 g·mol−1 |
Pharmacology | |
C07AB13 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Talinolol is a beta blocker.[1]
Talinolol contains a stereocenter and consists of two enantiomers. This is a racemate, i.e. a 1: 1 mixture of (R)- and the (S)-forms:[2]
Enantiomers of talinolol | |
---|---|
(R)-talinolol CAS number: 71369-60-3 |
(S)-talinolol CAS number: 71369-59-0 |
| |
---|---|
β, non-selective |
|
β1-selective |
|
β2-selective |
|
α1- + β-selective |
|
|
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |